HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy.

Abstract
Fourty-three episodes of fungaemia encountered from 1978 to 1991 in 43 patients with haematological malignancies are reviewed here to analyse the risk factors for death and to evaluate the efficacy of early antifungal therapy. Low serum cholinesterase and elevated serum blood urea nitrogen were significantly associated with fungaemic death, defined as death occurring within 2 weeks after documentation of fungaemia. Overall death rate from fungaemia was 62.8%. Before the introduction of early antifungal therapy in 1986, however, fungaemic mortality was 85.7%; it was reduced to 51.7% thereafter (p = 0.01). Determination of plasma (1-->3)-beta-D-glucan was helpful in detecting deep fungal infections and initiating antifungal therapy early.
AuthorsA Iwama, M Yoshida, A Miwa, T Obayashi, S Sakamoto, Y Miura
JournalEuropean journal of haematology (Eur J Haematol) Vol. 51 Issue 3 Pg. 156-60 (Sep 1993) ISSN: 0902-4441 [Print] DENMARK
PMID8405330 (Publication Type: Journal Article)
Chemical References
  • Antifungal Agents
  • Serum Albumin
  • Cholinesterases
Topics
  • Adolescent
  • Adult
  • Aged
  • Agranulocytosis
  • Antifungal Agents (therapeutic use)
  • Blood Urea Nitrogen
  • Candidiasis (drug therapy, etiology, mortality)
  • Child
  • Cholinesterases (blood)
  • Female
  • Fungemia (drug therapy, etiology, mortality)
  • Hematologic Diseases (complications)
  • Humans
  • Leukemia (complications)
  • Lymphoma (complications)
  • Male
  • Middle Aged
  • Risk Factors
  • Serum Albumin (metabolism)
  • Survival Rate
  • Thrombocytopenia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: